Agios Pharmaceuticals, Inc. (AGIO) vs Maravai LifeSciences Holdings, Inc. (MRVI)
- Agios Pharmaceuticals, Inc. AGIO 31.32 −3.09%
- Maravai LifeSciences Holdings, Inc. MRVI 6.79 −3.96%
Agios Pharmaceuticals, Inc. and Maravai LifeSciences Holdings, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Maravai LifeSciences Holdings, Inc. are of similar size ($1.9B and $1.8B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against −5.03%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −418.2%) and the higher return on invested capital (−15.8% vs −70.2%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 13 and Agios Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | AGIO | MRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 34.89% | 65.16% |
| Operating margin | (466.78%) | (56.08%) | 0.00% |
| Net margin | (418.24%) | (37.07%) | 0.00% |
| Free cash flow margin | (371.43%) | (17.17%) | 0.00% |
| Return on equity | (34.34%) | (18.79%) | (56.36%) |
| Return on assets | (31.89%) | (10.31%) | (48.04%) |
| Return on invested capital | (70.24%) | (15.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack